Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States

The goal of this analysis was to provide a contemporary estimate of the burden of migraine, incorporating both direct and indirect costs, by comparing the costs of migraine patients to a matched group of patients without migraine in a large, nationally representative sample of commercially insured patients in the United States.

[1]  K. Widnell,et al.  Factors Associated with Direct Health Care Costs Among Patients with Migraine. , 2017, Journal of managed care & specialty pharmacy.

[2]  P. Kawalec.  Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review , 2016, Archives of medical science : AMS.

[3]  R. Lipton,et al.  Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web‐Based Survey , 2016, Headache.

[4]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[5]  E. Loder,et al.  The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies , 2015, Headache.

[6]  R. Ohrbach,et al.  The International Classification of Headache Disorders, 3rd edition (beta version) , 2013, Cephalalgia : an international journal of headache.

[7]  Elizabeth Loder,et al.  The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies , 2013, Headache.

[8]  D. Polsky,et al.  Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults , 2012, BMC Health Services Research.

[9]  D. Mannino,et al.  Incidence and cost of CAP in a large working-age population. , 2012, The American journal of managed care.

[10]  R. Lipton,et al.  Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS) , 2012, The Journal of Headache and Pain.

[11]  M. Stokes,et al.  Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS) , 2011, Headache.

[12]  R. Lipton,et al.  Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) , 2011, Cephalalgia : an international journal of headache.

[13]  R. Kessler,et al.  Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance , 2010, Depression and anxiety.

[14]  R. Lipton,et al.  Employment and Work Impact of Chronic Migraine and Episodic Migraine , 2010, Journal of occupational and environmental medicine.

[15]  M. Láinez.  The Effect of Migraine Prophylaxis on Migraine-Related Resource Use and Productivity , 2009, CNS drugs.

[16]  S. Silberstein.  Preventive Migraine Treatment , 2009, Neurologic clinics.

[17]  Raymond H. Phillippi,et al.  The Direct and Indirect Costs of Employee Depression, Anxiety, and Emotional Disorders—An Employer Case Study , 2009, Journal of occupational and environmental medicine.

[18]  Kristen E Downs,et al.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. , 2009, Mayo Clinic proceedings.

[19]  R. Lipton,et al.  Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study , 2009, Headache.

[20]  K. Hawkins,et al.  Direct Cost Burden Among Insured US Employees With Migraine , 2008, Headache.

[21]  R. Ozminkowski,et al.  The Direct and Indirect Cost Burden of Clinically Significant and Symptomatic Uterine Fibroids , 2007, Journal of occupational and environmental medicine.

[22]  Richard R. Cline,et al.  Effect of daily migraine prevention on health care utilisation in an insured patient population , 2007, The Journal of Headache and Pain.

[23]  Kevin Hawkins,et al.  Indirect Cost Burden of Migraine in the United States , 2007, Journal of occupational and environmental medicine.

[24]  R. Lipton,et al.  Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.

[25]  J. Reginster,et al.  Direct and indirect costs attributable to osteoarthritis in active subjects. , 2006, The Journal of rheumatology.

[26]  R. Lipton,et al.  The medical care utilization and costs associated with migraine headache , 2004, Journal of General Internal Medicine.

[27]  M. Lage,et al.  The Medical Costs of Migraine and Comorbid Anxiety and Depression , 2004, Headache.

[28]  J. Edmeads,et al.  The Economic Impact of Migraine: An Analysis of Direct and Indirect Costs , 2002, Headache.

[29]  W F Stewart,et al.  Burden of migraine in the United States: disability and economic costs. , 1999, Archives of internal medicine.

[30]  W. Stewart,et al.  Headache and migraine: a leading cause of absenteeism. , 2015, Handbook of clinical neurology.

[31]  R. Lipton,et al.  Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  M. Lanteri-Minet.  Economic Burden and Costs of Chronic Migraine , 2013, Current Pain and Headache Reports.

[33]  R. Lipton,et al.  The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  I. Garza.  Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment , 2009 .

[35]  M. Rupnow,et al.  Resource utilization impact of topiramate for migraine prevention in the managed-care setting. , 2009, Current medical research and opinion.